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Background: This study was performed to find the optimal volume of local anesthetics needed for a successful 
ultrasound-guided stellate ganglion block (SGB) to treat head and neck pathology.
Methods: Fifteen female and fourteen male sensory-neural hearing loss patients received 4 times SGBs with 0.2% 
ropivacaine in volumes of 6, 4, 3 and 2 ml at 1 to 3 day intervals. Using the transverse short-axis view of the neck that 
showed Chassaignac's tubercle at the C6 level, a 25-gauge, and 4 cm needle was inserted via the lateral paracarotid 
approach with out-of-plane targeting between the prevertebral fascia and the ventral surface of longus colli muscle 
(subfascial injection). A successful block was confirmed with the onset of ptosis (Horner's syndrome).
Results: There were no significant statistical differences between the presence of Horner's syndrome and the volume 
of local anesthetics given. However, Horner's syndrome was present in all trials for the 4 ml and 6 ml groups. Six 
(20.7%) and three out (10.4%) of twenty-nine trials in the 2 ml and 3 ml groups, respectively, failed to elicit Horner's 
syndrome. The duration of action was significantly different in the 2 ml group compared to that of the 6 ml group, but 
there was no significant difference between the other groups, including the 4 ml vs. 6 ml groups. The side effects were 
not different between the groups.
Conclusions: This data suggests that the optimal volume of 0.2% ropivacaine for ultrasound-guided SGB to treat the 
head and neck pathology in daily practice is 4 ml. (Korean J Anesthesiol 2011; 60: 179-184)
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Introduction
    Several studies have focused on the optimal amount of local 
anesthetics needed for a successful stellate ganglion block 
(SGB). However, the previous studies were conducted by 
performing SGBs under the blind technique [1-5]. Furthermore, 
the reported minimum or optimal requirements of local 
anesthetics were controversial in the previous studies; 5 ml of 
1% mepivacaine [5], 8 ml of 0.2% ropivacaine [2], 8 ml of 0.5% 
lidocaine [3], or 6 ml of 1% lidocaine for head and neck disease 
and above 12 ml of 1% lidocaine for upper extremity disease [4]. 
Cho et al. [2] compared 8 ml of 1% lidocaine, 0.2% bupivacaine 
and 0.2% ropivacaine when used for SGB, and they reported 
0.2% ropivacaine was in the middle of these agents when its 
pharmacological properties were compared to the faster onset 
and short duration of lidocaine and the slowed onset and long 
duration of bupivacaine.
    We have used 6 ml of 0.2% ropivacaine for SGB in patients 
with a head and neck pathology in daily practice for several 
years based upon the results of previous studies [1-4], and we 
have recently adopted ultrasound imaging in daily practice for 
performing SGB.
    The ultrasound guidance technique for SGB was first 
published a case series by Kapral et al. [6] in 1995, but this 
technique has only recently gained popularity. Kapral et al. 
[6] found that ultrasound-guided SGB, as compared with the 
blind technique, used a lower volume of local anesthetics 
(5 ml rather than 8 ml) and there was a more rapid onset of 
Horner's syndrome. Narouze et al. [7] also used 5 ml of 0.25% 
bupivacaine for ultrasound-guided SGB. Application of 
ultrasound for regional nerve blockade has proven to be useful 
for the swift and accurate placement of local anesthetics on a 
targeted area [8], and it might reduce the required volume of 
local anesthetics as compared with that of the blind technique.
    Therefore, this study was performed to find the optimal 
volume of 0.2% ropivacaine for a successful ultrasound-guided 
SGB for head and neck pathologies in daily practice.
Materials and Methods
    After approval by the Institutional Review Board, 29 patients 
with sensory-neural hearing loss and who were referred to 
the pain clinic for SGB were selected. Fifteen women and 
fourteen men with a median age of 55.1 years (range: 38-73) 
were included in this study (Table 1). All the patients were ASA 
Physical Status 1 or 2 and they had no history of anticoagulant 
or coagulopathy.
    All the procedures were performed by the same anesthesio-
logist for a technical consistency. A double-blind, randomized 
study for the volume was conducted in which 0.2% ropivacaine 
was given to the patients. Each SGB was allocated into one of 
four different volume (6 ml, 4 ml, 3 ml or 2 ml) groups. Each 
patient received 4 SGBs, which were done by repeated trials 
using a randomized volume of the four different groups of 0.2% 
ropivacaine, with a washout interval of 1 to 3 days.
    The patients were positioned the same as for the classical 
blind technique, with the neck extended and this was aided 
by a 15 cm pillow placed under the shoulders, and the mouth 
slightly open to relieve tension of the neck. With the help of 
an ultrasound imaging device with a 13-16 MHz linear array 
probe (HFL38x, Sonosite M-Turbo
Ⓡ; Sonosite, Bothell, WA), 
which provided a transverse short-axis view of the neck and this 
showed the prominent anterior tubercle of the C6 transverse 
process (Chassaignac's tubercle) at the C6 level. The thyroid 
gland, the carotid artery, the compressible internal jugular vein, 
the prevertebral fascia (PVF), Chassaignac's tubercle and the 
oval shaped structure of the longus colli muscle were revealed 
on this short-axis view (Fig. 1). The color Doppler mode was 
used before needling to avoid penetrating blood vessels such 
as a vertebral artery, the inferior thyroid vessels and etc. A 
25-gauge, 4 cm needle (Kovax
Ⓡ) was advanced at the lateral 
Fig. 1. Sonoanatomy for an ultrasound-guided SGB: the transverse 
short-axis view at the C6 level. CA: carotid artery, IJV: internal jugular 
vein (in a partially compressed state by the probe), PVF: prevertebral 
fascia, LCo: longus colli muscle, SCM: sternocleidomastoid muscle, 
Thy: thyroid gland, T: Chassaignac's tubercle, med: medial, lat: 
lateral.
Table 1. Demographic Data
  Number of patients (M/F)
  Age (yr)
  Weight (kg)
  Height (cm)
  BMI (m
2/kg)
29 (14/5)
55.1 ± 9.6 (38-73)
64.0 ± 8.1 (48-79)
162.8 ± 8.1 (146-175)
24.1 ± 2.3 (19.4-27.7)
Values are means ± SDs (range).181 www.ekja.org
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paracarotid side with the out-of-plane approach, and the needle 
was inserted parallel and 0.2 cm apart from the probe on the 
skin. The needle tip was inserted at the middle of the lateral side 
of the carotid artery and Chassaignac's tubercle, and then it 
penetrated through the completely compressed internal jugular 
vein to the target point under the PVF and above the ventral 
surface of the longus colli muscle (a subfascial injection). All 
the procedure was continued real-time with visualization of 
the needle tip as an echogenic dot on the screen. Finally, the 
correct position of the needle was confirmed by the expansion 
of local anesthetics beneath the PVF and above the longus colli 
in the transverse view (Fig. 2). Injections were permitted after 
a negative aspiration test, and following injection of 0.2 ml of 
local anesthetics to rule out intravascular placement of the 
needle. Every injection was divided by less than 1 ml and the 
needle was repositioned several times to keep the exact position 
of the needle under direct visualization to prevent displacement 
of the needle and overshooting the injectate. After removal of 
the needle, manual compression of the injection site for 5 min 
was done to prevent hematoma formation. Thirty minutes later, 
the patient's neck was re-examined with ultrasound to check for 
hematoma formation before his/her discharge.
    The time of injection was recorded at the time of needle 
removal, and the onset of Horner’s syndrome, which was 
assessed by checking for signs of ptosis, was checked every 
minute thereafter. The time to relief of ptosis was recorded by 
the patient who was instructed to check every 30 minutes. The 
duration action of the local anesthetic was counted from the 
time of needle removal to the time of the relief of ptosis.
    Side effects were recorded upon recognition by the doctor 
during the patient’s recovery state in the clinic. The common 
side effects were checked, including hoarseness, dysphagia and 
a foreign body sensation in the throat, upper extremity weakness, 
and hematoma formation. The patients were instructed to 
inform the doctor of any adverse symptoms they experienced 
upon their next visit.
    The data was analyzed using SPSS version 15.0 (SPSS Inc., 
Chicago, IL, USA) and the results were expressed as means ± 
SDs. To compare the differences between the groups, Fisher's 
exact tests were used for the rates of occurrence of ptosis and 
side effects after SGB, and Kruskal-Wallis test was used for the 
analysis of the onset time and the duration of action. P value 
less than 0.05 was considered statistically significant.
Results
    Positive cranial sympathetic blockade (Horner's syndrome) 
following ultrasound-guided SGB was present in all the trials in 
the 4 ml and 6 ml groups with using 0.2% ropivacaine (Table 2). 
Six (20.7%) and 3 (10.4%) out of the twenty-nine trials in 2 ml 
and 3 ml groups respectively, failed to elicit Horner's syndrome. 
However, there were no statistically significant differences 
between the presence of Horner's syndrome and the volume 
of local anesthetics given (P > 0.05, Fisher's exact test). Also, 
the onset time was not statistically different between the four 
groups (Table 2, P > 0.05, Kruskal-Wallis test).
    The action duration was 134.3 ± 44.1, 158.5 ± 64.5, 165.5 ± 60.3 
and 197.6 ± 87.6 min in the 2 ml, 3 ml, 4 ml and 6 ml groups, 
respectively (Table 2). The duration of action was significantly 
different between the 2 ml and 6 ml groups (P < 0.001, Kruskal-
Wallis test), but the duration of action was not significantly 
different between the 2 ml vs. 3 ml, 2 ml vs. 4 ml, 3 ml vs. 4 ml, 3 
Table 2. Comparison of the Four Different Volumes of 0.2% Ropivacaine used for an Ultrasound-guided SGB (N = 29)
Volume of 0.2% ropivacaine 2 ml  3 ml 4 ml 6 ml
  Horner's syndrome (%)
  Onset time (min)
  Action duration (min)
  23 (79.3)*
3.9 ± 1.6
134.3 ± 44.1
†
  26 (89.6)*
3.8 ± 2.5 
158.5 ± 64.5
29 (100)
3.5 ± 2.2
165.5 ± 60.3
29 (100)
3.2 ± 1.7
197.6 ± 87.6
Values are means ± SDs. *The 2 ml and 3 ml groups appeared to have a lower incidence rate of Horner's syndrome than those of the 4 ml and 
6 ml groups, but there was no significant difference (P > 0.05). 
†The duration of action was significantly different between the 2 ml and 6 ml 
groups (P < 0.001, Kruskal-Wallis test), but it was not significantly different between the other groups (P > 0.05). SGB: stellate ganglion block.
Fig. 2. Ultrasound image of the C6 transverse short-axis view 
following left SGB at the C6 level. Arrows show the subfascial spread 
of local anesthetics above the longus colli muscle. The fine long 
arrow indicates the out-of-plane needle path. CA: carotid artery, 
LCo: longus colli muscle, SCM: sternocleidomastoid muscle, Thy: 
thyroid gland, T: Chassaignac's tubercle, med: medial, lat: lateral.182 www.ekja.org
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ml vs. 6 ml and 4 ml vs. 6 ml groups (P > 0.05).
    The side effects were revealed as follows. Hoarseness was 
the most common side effect (Table 3). The incidences of the 
hoarseness were 10.3%, 6.9%, 10.3% and 6.9% in the 2 ml, 3 
ml, 4 ml and 6 ml groups, respectively, without significant 
differences between the groups. Dysphagia was noted in one 
case each in the 3 ml, 4 ml and 6 ml groups (each 3.4%), and a 
foreign body sensation was revealed in only one case in the 6 ml 
group (3.4%). All the groups were similar for being free of upper 
extremity weakness and hematoma formation. Although diverse 
side effects were seen, there were no statistically significant 
differences between the groups (Table 3, P > 0.05, Fisher's exact 
test).
Discussion
    To find the optimal volume of 0.2% ropivacaine required for a 
successful ultrasound-guided SGB for head and neck pathology, 
we performed a double blind randomized study on 29 patients 
with sensory-neural hearing loss. All the patients received four 
times ultrasound-guided SGBs separately using a volume of 
four different volumes of 0.2% ropivacaine. All the patients in 
the 4 ml and 6 ml groups displayed Horner's syndrome, while 
some of the patients in the 2 ml and 3 ml groups failed to elicit 
Horner’s syndrome. Furthermore, there were no differences in 
the onset time, the duration of action and the incidence of the 
side effects in the 4 ml and 6 ml groups. Therefore, the authors 
of this study recommend that 4 ml is the optimal volume of 0.2% 
ropivacaine for performing an ultrasound-guided SGB for the 
patients with head and neck pathologies.
    Stellate ganglion blocks are performed for the purpose of 
blocking the sympathetic innervations of the cranial and cervical 
nerves and sometimes the nerves of the upper extremities. 
Sympathetic outflow from the white rami communicants of the 
upper thoracic nerves enter the corresponding sympathetic 
ganglia and then they ascend into the neck, where they are 
fused into ganglions: the superior, middle, inferior and the 
cervicothoracic ganglions. Among them, the cervicothoracic 
ganglion (a fusion of the inferior cervical and first thoracic 
ganglions), which is also called stellate ganglion, was not the 
target for blockade in this study. Only the blockade of the 
middle or inferior cervical ganglion was needed to promote 
blood flow to the cranial area for our patients with acute 
sensory-neural hearing loss, and to elicit Horner's syndrome. 
Horner’s syndrome (ptosis, miosis and enophthalmos), 
as well as ipsilateral flushing of the conjunctiva and skin, 
blocking of the nose and anhydrosis, are the result when the 
cervical sympathetic fibers are successfully blocked [9]. The 
development of Horner’s syndrome is usually taken to mean 
that an accurate SGB for the head and neck area has been done, 
but not for the upper extremity [9,10]. It has been used as an 
indicator for successful cervical sympathetic block [2,3,5,6,9-
11]. Furthermore, ptosis is the most common sign (100%) after 
SGB [11]. We used the development of Horner's syndrome 
(and especially ptosis) as an indicator for successful cervical 
sympathetic block in this study. Although the location or even 
the presence of the stellate ganglion varies among patients, 
numerous trials [1-7] have shown that SGB performed at the 
level of the C6 transverse process is sufficient for the blockade 
of the sympathetic innervations of the cranial area, and we also 
performed US-guided SGB at the level of the C6 tubercle in this 
study.
    Many imaging devices have been studied for enhancing the 
accuracy of SGBs to prevent the serious side effects such as 
epidural [12], subarachnoid [13] and intra-arterial injections 
[14,15]. Among these, computerized tomography [16] and MRI 
[17] are considered to be time-consuming and expensive, and 
most of all they are impractical for most practitioners [18]. 
Fluoroscopy has gained popularity for its convenience and the 
relatively familiar real-time imaging, but fluoroscopy still cannot 
prevent improper injections into other important anatomical 
structures, such as the esophagus, which may be accidentally 
punctured and this can lead to infection of the neck [7,19].
    The ultrasound guidance technique was first published in a 
case series by Kapral et al. [6] in 1995, but it has only recently 
gained popularity. They found that ultrasound-guided SGB, 
compared with the blind technique, used a lower volume 
of local anesthetics (5 ml rather than 8 ml) and it showed a 
more rapid onset of Horner's syndrome. Narouze et al. [7] 
also used 5 ml of 0.25% bupivacaine for ultrasound-guided 
SGB. Application of ultrasound for regional nerve blockade 
has proven to be useful for the accurate placement of local 
anesthetics on a targeted area [8], and it might reduce the 
volume of local anesthetics compared with that of the blind 
approach.
    In this study, the lateral paracarotid out-of-plane technique 
was used when performing an ultrasound-guided SGB. The out-
of-plane injection technique used in this study was different 
Table 3. The Comparison of the Side Effects according to the Injected 
Volume for an Ultrasound-guided SGB using 0.2% Ropivacaine (N = 29)
Volume of 0.2% ropivacaine 2 ml  3 ml 4 ml 6 ml
 Hoarseness (%)
 Swallowing difficulty (%)
 Foreign body sensation (%)
 Upper extremity weakness
 Hematoma formation
3 (10.3)
0
0
0
0
2 (6.9)
1 (3.4)
0
0
0
3 (10.3)
1 (3.4)
0
0
0
2 (6.9)
1 (3.4)
1 (3.4)
0
0
There were several side effects following SGB in each group. However, 
there were no significant differences between the groups (P > 0.05, 
Fisher's exact test). SGB: stellate ganglion block.183 www.ekja.org
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from the lateral paracarotid in-plane injection technique 
reported by Gofeld et al. [20]. The insertion point of the needle 
was at the middle between the lateral side of the carotid and 
the medial border of Chassaignac's tubercle, and the target 
area was into just beneath the PVF and above the longus colli 
muscle (a subfascial injection). Therefore, the needle passed 
through the compressed internal jugular vein (Fig. 2). With this 
technique, repeated injections precisely at the level of C6 were 
possible by confirmation of the subfascial expansion during 
injection (Fig. 2). Two concerns are possible with using this 
technique. The first is the needle path penetrating the internal 
jugular vein. We were concerned about this before our trials, 
but it might not be problematic if the procedure is carefully 
performed because the vein was completely compressed during 
procedure and no hematoma formation occurred following 
the procedure. The second is the concern about the out-of-
plane approach. There is controversy about the in-plane vs. 
out-of plane needle approaches for ultrasound-guided nerve 
blocks [21,22]. The pros and cons for both methods have 
been debated and there is no data showing that one is better 
than the other. The method is generally chosen according to 
the operator's preference. Although out-of-plane is criticized 
because of the poor visualization of the needle tip and its 
related complications, the operator's skill is the most important 
variable that influences the needle’s visibility [21]. Actually in 
this study, we carefully performed out-of-plane approaches 
with special attention including that the needle was inserted 
at 0.2 cm apartand perpendicularly down at nearly parallel to 
the probe (the ultrasound beam) to get better visualization, 
and the probe was intermittently angled during the procedure 
for real-time confirmation of the needle tip with the echogenic 
dot disappearing distal to it [22]. Further details about the 
technique are not needed for this volume study.
    There is agreement that larger volumes (more than 10 ml) of 
local anesthetics for SGB are needed for blockade of the upper 
extremity pathologies [1,23]. However, the optimal volume 
for the head and neck is still controversial. Large volumes 
exceeding 10 ml of local anesthetics were not needed in this 
study for the purpose of cranial sympathetic blockade in 
patients with sudden sensory-neural hearing loss. Kapral et 
al. [6] and Narouze et al. [7] used 5 ml of local anesthetics for 
ultrasound-guided SGB. Lee et al. [5] recommended 5 ml, and 
others [1-4] have recommended 6-8 ml as the optimal volume 
for SGB using the classical blind technique.
    In a preliminary study, we experienced that only 1 or 2 ml of 
0.2% ropivacaine was enough for ultrasound-guided SGB in 
some patients. However, the optimal volume in daily practice 
means that there is no failure according to the small volume of 
local anesthetics injected into an exact targeted area. Also, in 
this study, ultrasound-guided SGBs were effectively performed 
even with 2 ml in some patients, but not in all. The failure 
rate of the 2 ml groups was 20.7%. It means that 2 ml of local 
anesthetics is not optimal in daily practice. Although the success 
rates were not significantly different between the four groups, 
both the 2 ml (79.3%) and 3 ml (89.6%) groups did not reach 
100%, which is unlike the 4 ml and 6 ml groups. Furthermore, 
the duration of action was significantly different between the 
2 ml and 6 ml groups (P < 0.001, Kruskal-Wallis test), but there 
was no significant difference between the 4 ml and 6 ml groups 
(P > 0.05). Therefore, 4 ml of 0.2% ropivacaine, instead of 6 ml, 
was more optimal for successful SGB, and 2 or 3 ml, which was 
expected to be optimal before the study, was not sufficient for 
routine SGB. Our data showed that 4 ml was an optimal volume 
for ultrasound-guided SGB, and this volume was lower than 
those previously reported volumes of the blind technique (5-8 
ml) [1-5] and it was also a little lower than previously reported 
volumes for ultrasound-guided SGB (5 ml) [6,7]. By the way, 
4 ml as an optimal volume for an ultrasound-guided SGB was 
larger than we expected before the study. The cause of the 
required larger volume might be the lack of the pressure effect 
as compared with that of blind injection, which is performed in 
the compressed space around the longus colli muscle. Lee et al. 
[24] reported digital compression during injection for SGB with 
the blind technique affected the spread of local anesthetics; 
6 ml with digital compression showed a similar increase of 
skin temperature compared with that for 10 ml without digital 
compression.
    There were several side effects following SGB such as 
hoarseness, a foreign body sensation and dysphagia in all the 
groups, and the occurrence rate was considerably lower than 
those of the previous studies that used larger volumes of local 
anesthetics. However, our study failed to show a comparable 
difference of the rate of occurrence of side effects between 
the groups. Although there was a three-fold difference of the 
volume between the minimum (2 ml) and maximum (6 ml) 
volume administered, the rate of occurrence of side effects was 
low in all four groups, without relevance to the volume. The 
ultrasound-guided technique may also have contributed to the 
low rate of side effects due to its ability to help accurately inject 
into the target space and thereby prevent accidental injection.
    Several studies with volumes larger than 5 ml have shown 
the spread of the injectate into distant areas with reaching 
several nervous structures such as the carotid baroreceptor and 
the vagus nerve [25,26]. Thus, hemodynamic regulation may 
be hindered [27]. Severe hypertension may be elicited by the 
unopposed cardiac sympathetic stimulation by blockade of the 
vagus nerve [28,29]. However, hypertension may be induced 
even by a small volume of local anesthetics. Kimura et al. [29] 
reported seven cases of severe hypertension after SGB using 
5 ml of 1% mepivacaine. As we have not experienced severe 184 www.ekja.org
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hypertension in our facility using 0.2% ropivacaine for all our 
SGBs, the type or the permeability of the local anesthetics used 
may be more of importance rather than the amount [30]. These 
differences of local anesthetics might require further studies.
    In conclusion, this SGB volume study shows that large 
volumes of local anesthetics are not required when performing 
ultrasound-guided SGB. Although the 2 ml group in this study 
showed as effective as those of the 4 ml and 6 ml groups without 
any statistically significant difference, the 2 ml and 3 ml groups 
showed a meaningful failure rate. Therefore, we recommend 
that the optimal volume of 0.2% ropivacaine for ultrasound-
guided SGB to treat head and neck pathology in daily practice 
is 4 ml. Two ml or 3 ml are not optimal for a routine SGB unless 
further large scale studies support using lower volumes.
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